Drug intelligence / Profile preview

12AC2O

Development stage
Preclinical
Lead developer
Tohoku Medical and Pharmaceutical University
Modality
Small Molecules
01

Overview

12AC2O is a synthetic organic gem-dihydroperoxide (DHP) compound developed as a potential therapeutic agent for amyotrophic lateral sclerosis (ALS). It functions as a potent antioxidant and free radical scavenger, specifically targeting hydroxyl radicals and superoxide anions to mitigate oxidative stress, which is a key driver of ALS pathology. Preclinical research has demonstrated that 12AC2O can significantly inhibit cell death and reduce the accumulation of misfolded protein aggregates induced by mutant copper-zinc superoxide dismutase (SOD1). By addressing both the oxidative damage and the protein aggregation associated with mutant SOD1, 12AC2O represents a novel approach to neuroprotection in neurodegenerative disorders.

Other names
12AC2Ogem-dihydroperoxide 12AC2Ogem-dihydroperoxide12AC2Ogem-dihydroperoxide-12AC2O
02

Targets

Misfolded SOD1

Beyond the preview

Go deeper on 12AC2O.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 12AC2O.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call